MedTrace Logo

A Clinical Trial of Bio-Germanium for the Evaluation of Efficacy on Immune Function

NCT03677921 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2018-09-20

No results posted yet for this study

Summary

This study is a 8-week, randomized, double-blind, placebo-controlled clinical trial of Bio-Germanium for the evaluation of efficacy on immune function and immune cell activation.

Conditions

  • Normal Healthy Subjects

Interventions

DIETARY_SUPPLEMENT

Investigational Product (Bio-Germanium)

* Ingredient: Bio-Germanium * Type: HPMC capsule * Weight: 300mg/capsule * Directions: 2 capsules, twice a day (1.2g/day of Bio-Germanium) * Storage: Room temperature (below 25℃) * Duration of use: 8 weeks

DIETARY_SUPPLEMENT

Control Group - Placebo Product

* Ingredient: Corn starch * Type: HPMC capsule * Weight: 300mg/capsule * Directions: 2 capsules, twice a day * Storage: Room temperature (below 25℃) * Duration of use: 8 weeks

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • JONGHO LEE, Ph.D. · Yonsei University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-10
Primary Completion
2018-08-10
Completion
2018-09-10

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03677921 on ClinicalTrials.gov